Featured 13F manager
Farallon Capital Management, L.l.c.
San Francisco, CA 87 processed 13Fs on this site · 2021 Q3–2026 Q2
- $21.7B
- 77 Positions
- 2026 Q2
- +23.6% QoQ
- Top 5 29.9%
Portfolio
top 5 29.9% · top 10 44.0%
- RVMD - Revolution Medicines 11.7%
- EA - Electronic Arts 7.5%
- BBIO - Bridgebio Pharma 3.7%
- PTGX - Protagonist Therapeutics 3.6%
- EXEL - Exelixis 3.4%
- LQDA - Liquidia 3.1%
- AMZN - Amazon 2.9%
- LNTH - Lantheus 2.9%
- NTRA - Natera 2.8%
- UNH - Unitedhealth Group 2.4%
- TMO - Thermo Fisher Scientific 2.4%
- ROIV - Roivant Sciences 2.3%
- Other 51.3%
AUM over time
Book
| MSFT - Microsoft | 4.78% | Add +40.0% | 2,285,835 | $375.39 | $858M | +652,688 | +$170M |
| EXEL - Exelixis | 4.64% | Reduce −3.9% | 22,533,500 | $36.92 | $832M | −906,000 | +$51M |
| UNH - Unitedhealth Group | 4.37% | Add +2.4% | 1,497,900 | $523.75 | $785M | +35,400 | +$45M |
| NTRA - Natera | 3.59% | Add +2.6% | 4,547,809 | $141.41 | $643M | +116,200 | −$58M |
| IQV - IQVIA | 3.35% | Add +9.2% | 3,411,851 | $176.30 | $602M | +288,700 | −$12M |
| LNTH - Lantheus | 3.28% | Add +13.3% | 6,023,227 | $97.60 | $588M | +707,000 | +$112M |
| ARMK - Aramark | 3.13% | Add +42.3% | 16,241,996 | $34.52 | $561M | +4,831,656 | +$135M |
| DIS - Disney Walt | 3.02% | Add +24.1% | 5,496,223 | $98.70 | $542M | +1,068,155 | +$49M |
| CRM - Salesforce | 2.94% | Add +62.6% | 1,967,110 | $268.36 | $528M | +756,972 | +$123M |
| ADSK - Autodesk | 2.92% | Add +8.4% | 1,997,400 | $261.80 | $523M | +155,600 | −$21M |
| INTU - Intuit | 2.88% | Add +11.5% | 840,258 | $613.99 | $516M | +86,500 | +$42M |
| TMO - Thermo Fisher Scientific | 2.87% | Reduce −16.0% | 1,035,856 | $497.60 | $515M | −197,400 | −$126M |
| RVMD - Revolution Medicines | 2.67% | Add +2.2% | 13,534,692 | $35.36 | $479M | +286,000 | −$101M |
| TRU - Transunion | 2.50% | Add +1.6% | 5,413,206 | $82.99 | $449M | +86,887 | −$45M |
| NYT - New York Times · CL A | 2.47% | Add +21.1% | 8,932,113 | $49.60 | $443M | +1,556,000 | +$59M |
| Intra-Cellular Therapies | 2.25% | New | 3,055,000 | $131.92 | $403M | +3,055,000 | +$403M |
| BSX - Boston Scientific | 2.12% | Reduce −25.1% | 3,762,757 | $100.88 | $380M | −1,260,200 | −$69M |
| AON - AON PLC · CL A | 2.11% | Reduce −25.7% | 1,361,744 | $277.83 | $378M | −470,989 | −$280M |
| MCK - Mckesson | 2.07% | Reduce −9.5% | 552,500 | $672.99 | $372M | −58,200 | +$24M |
| NDAQ - Nasdaq | 1.89% | Add +11.6% | 4,460,288 | $75.86 | $338M | +462,269 | +$29M |
| CBRE - CBRE Group · CL A | 1.82% | Add +14.5% | 2,495,700 | $130.78 | $326M | +315,900 | +$40M |
| SCHW - Schwab Charles | 1.67% | Add +20.9% | 3,832,857 | $78.28 | $300M | +663,857 | +$65M |
| PTGX - Protagonist Therapeutics | 1.65% | Add +3.0% | 6,107,006 | $48.36 | $295M | +177,000 | +$66M |
| WAB - Wabtec | 1.63% | Add +12.4% | 1,608,098 | $181.35 | $292M | +177,900 | +$20M |
| GBTC - Ishares Bitcoin Trust ETF | 1.51% | Reduce −20.2% | 5,793,800 | $46.81 | $271M | −1,465,300 | −$114M |
| ADI - Analog Devices | 1.49% | Add +14.7% | 1,327,000 | $201.67 | $268M | +169,800 | +$22M |
| GOOG - Alphabet · CL C | 1.45% | Reduce −19.9% | 1,666,040 | $156.23 | $260M | −414,500 | −$136M |
| WWD - Woodward | 1.44% | Reduce −6.7% | 1,419,700 | $182.49 | $259M | −101,600 | +$6M |
| HIMS - Hims & Hers Health · CL A | 1.31% | Reduce −5.1% | 7,953,705 | $29.55 | $235M | −423,295 | +$32M |
| BBIO - Bridgebio Pharma | 1.10% | Add +36.6% | 5,731,000 | $34.57 | $198M | +1,536,000 | +$83M |
| BEAM - Beam Therapeutics | 1.08% | Add +20.5% | 9,928,111 | $19.53 | $194M | +1,688,988 | −$10M |
| AGIO - Agios Pharmaceuticals | 0.93% | Add +0.5% | 5,700,466 | $29.30 | $167M | +26,000 | −$19M |
| V - VISA · CL A | 0.93% | Reduce −13.7% | 474,210 | $350.46 | $166M | −75,300 | −$7M |
| CRNX — | 0.86% | Add +13.0% | 4,605,098 | $33.54 | $154M | +530,000 | −$54M |
| Sarepta Therapeutics | 0.83% | Reduce −18.3% | 2,341,424 | $63.82 | $149M | −523,676 | −$199M |
| BHVN - Biohaven | 0.65% | Add +8.7% | 4,813,167 | $24.04 | $116M | +385,000 | −$50M |
| MA - Mastercard · CL A | 0.62% | Reduce −31.9% | 201,371 | $548.12 | $110M | −94,300 | −$45M |
| YMM - Full Truck Alliance | 0.52% | Reduce −55.6% | 7,357,207 | $12.77 | $94M | −9,227,888 | −$85M |
| SGI - Somnigroup International | 0.44% | New | 1,326,242 | $59.88 | $79M | +1,326,242 | +$79M |
| WAY - Waystar | 0.42% | Add +50.5% | 2,020,000 | $37.36 | $75M | +678,000 | +$26M |
| Verona Pharma | 0.38% | New | 1,084,989 | $63.49 | $69M | +1,084,989 | +$69M |
| EHC - Encompass Health | 0.35% | Add +34.3% | 619,000 | $101.28 | $63M | +158,000 | +$20M |
| EDU — | 0.35% | Reduce −44.7% | 1,305,150 | $47.81 | $62M | −1,054,000 | −$89M |
| CNTA - Centessa Pharmaceuticals | 0.35% | Add +23.9% | 4,334,318 | $14.38 | $62M | +835,609 | +$4M |
| LQDA - Liquidia | 0.33% | Add +21.3% | 3,990,956 | $14.75 | $59M | +700,000 | +$20M |
| FLUT - Flutter Entmt | 0.30% | Add +167.4% | 241,467 | $221.55 | $53M | +151,167 | +$30M |
| ALKS - Alkermes | 0.26% | New | 1,389,800 | $33.02 | $46M | +1,389,800 | +$46M |
| ABT - Abbott Labs | 0.25% | New | 333,000 | $132.65 | $44M | +333,000 | +$44M |
| GEHC - GE HealthCare | 0.24% | Add +333.1% | 537,000 | $80.71 | $43M | +413,000 | +$34M |
| BBNX - Beta Bionics | 0.23% | New | 3,332,220 | $12.24 | $41M | +3,332,220 | +$41M |
| CAH - Cardinal Health | 0.21% | New | 273,000 | $137.77 | $38M | +273,000 | +$38M |
| HQY - Healthequity | 0.21% | Add +14964.3% | 421,800 | $88.37 | $37M | +419,000 | +$37M |
| JOYY — | 0.18% | New | 780,000 | $41.98 | $33M | +780,000 | +$33M |
| WGS - Genedx · CL A | 0.15% | Add +55.4% | 303,000 | $88.56 | $27M | +108,000 | +$12M |
| CAPR - Capricor Therapeutics | 0.12% | Hold | 2,250,400 | $9.49 | $21M | — | — |
| VNET - VNET Group | 0.11% | Add +275.2% | 2,439,120 | $8.20 | $20M | +1,789,120 | +$17M |
| Savara | 0.11% | Hold | 6,835,000 | $2.77 | $19M | — | — |
| Latam Airlines Group SA | 0.10% | Reduce −9.1% | 562,010 | $31.28 | $18M | −56,459 | +$522K |
| TECX - Tectonic Therapeutic | 0.08% | Add +19.6% | 853,050 | $17.71 | $15M | +140,000 | −$18M |
| ENTA - Enanta Pharmaceuticals | 0.07% | Add +0.7% | 2,122,262 | $5.52 | $12M | +14,000 | −$408K |
| NUVL - Nuvalent | 0.06% | Hold | 150,000 | $70.92 | $11M | — | — |
| TYRA - Tyra Biosciences | 0.06% | Add +14.3% | 1,143,818 | $9.30 | $11M | +142,837 | −$3M |
| MARA | 0.05% | Add +50.5% | 835,000 | $11.50 | $10M | +280,000 | +$295K |
| VYGR - Voyager Therapeutics | 0.05% | Hold | 2,570,700 | $3.38 | $9M | — | — |
| Helix Acquisition Ii · CL A | 0.04% | Hold | 600,000 | $11.30 | $7M | — | — |
| TNGX - Tango Therapeutics | 0.04% | Add +15.3% | 4,610,930 | $1.37 | $6M | +610,930 | −$6M |
| GMED - Globus Med · CL A | 0.03% | Add +2205.6% | 83,000 | $73.20 | $6M | +79,400 | +$6M |
| Springworks Therapeutics | 0.03% | New | 118,000 | $44.13 | $5M | +118,000 | +$5M |
| Zymeworks | 0.03% | Reduce −69.9% | 400,000 | $11.91 | $5M | −929,974 | −$15M |
| Rxsight | 0.02% | New | 175,000 | $25.25 | $4M | +175,000 | +$4M |
| Verve Therapeutics | 0.02% | New | 912,000 | $4.57 | $4M | +912,000 | +$4M |
| SMC - Summit Midstream | 0.01% | Hold | 58,214 | $33.89 | $2M | — | — |
| ALVO - Alvotech | 0.01% | Hold | 199,675 | $9.67 | $2M | — | — |
| Marblegate Acquisition · CL A | 0.01% | Hold | 150,000 | $11.05 | $2M | — | — |
| PRME - Prime Medicine | 0.01% | Hold | 750,000 | $1.99 | $1M | — | — |
| SIMO - Silicon Motion Technology | 0.01% | Reduce −92.9% | 29,298 | $50.56 | $1M | −385,702 | −$21M |
| LIVN - Livanova | 0.01% | New | 37,000 | $39.28 | $1M | +37,000 | +$1M |
| Janux Therapeutics | 0.01% | Hold | 48,000 | $27.00 | $1M | — | — |
| Biodesix | 0.01% | Reduce −51.2% | 1,859,308 | $0.6252 | $1M | −1,952,118 | −$5M |
| MDGL - Madrigal Pharmaceuticals | 0.01% | Hold | 3,319 | $331.23 | $1M | — | — |
| Cara Therapeutics | 0.00% | Hold | 129,685 | $5.07 | $658K | — | — |
| Forte Biosciences | 0.00% | Add +101.2% | 70,429 | $7.76 | $547K | +35,429 | −$248K |
| AXSM - Axsome Therapeutics | 0.00% | Hold | 4,000 | $116.63 | $467K | — | — |
| ARQT - Arcutis Biotherapeutics | 0.00% | Hold | 26,000 | $15.64 | $407K | — | — |
| PGNY - Progyny | 0.00% | Hold | 18,000 | $22.34 | $402K | — | — |
| BTSG - Brightspring Health Svcs | 0.00% | Hold | 22,000 | $18.09 | $398K | — | — |
| ROIV - Roivant Sciences | 0.00% | Hold | 37,000 | $10.09 | $373K | — | — |
| KRYS - Krystal Biotech | 0.00% | Hold | 2,000 | $180.30 | $361K | — | — |
| SLNOEUR - Soleno Therapeutics | 0.00% | Reduce −94.4% | 5,000 | $71.45 | $357K | −85,000 | −$4M |
| Blueprint Medicines | 0.00% | Hold | 4,000 | $88.51 | $354K | — | — |
| Sage Therapeutics | 0.00% | Hold | 42,800 | $7.95 | $340K | — | — |
| MMSI - Merit Med Sys | 0.00% | Hold | 3,000 | $105.71 | $317K | — | — |
| UTHR - United Therapeutics | 0.00% | Hold | 1,000 | $308.27 | $308K | — | — |
| TWST - Twist Bioscience | 0.00% | Hold | 7,650 | $39.26 | $300K | — | — |
| ONC - Beigene | 0.00% | Hold | 1,100 | $272.17 | $299K | — | — |
| COR - Cencora | 0.00% | Hold | 1,000 | $278.09 | $278K | — | — |
| ACLXGBX - Arcellx | 0.00% | Hold | 4,000 | $65.60 | $262K | — | — |
| GKOS - Glaukos | 0.00% | Hold | 2,600 | $98.42 | $256K | — | — |
| CHE - Chemed | 0.00% | Hold | 400 | $615.32 | $246K | — | — |
| SBRA - Sabra Health Care Reit | 0.00% | Hold | 14,000 | $17.47 | $245K | — | — |
| INSM - Insmed | 0.00% | Hold | 3,000 | $76.29 | $229K | — | — |
| SRRK - Scholar Rock | 0.00% | Hold | 7,000 | $32.15 | $225K | — | — |
| BRKR - Bruker | 0.00% | Hold | 5,000 | $41.74 | $209K | — | — |
| IMVT - Immunovant | 0.00% | Hold | 12,000 | $17.09 | $205K | — | — |
| HR - Healthcare Rlty Tr · CL A | 0.00% | Reduce −99.6% | 12,000 | $16.90 | $203K | −3,252,000 | −$55M |
| ARWR - Arrowhead Pharmaceuticals | 0.00% | Reduce −97.5% | 15,800 | $12.74 | $201K | −613,000 | −$12M |
| GRFS - Grifols S A | 0.00% | Hold | 28,000 | $7.11 | $199K | — | — |
| ELAN - Elanco Animal Health | 0.00% | Hold | 16,000 | $10.50 | $168K | — | — |
| PACB — | 0.00% | Hold | 135,000 | $1.18 | $159K | — | — |
| OSCR - Oscar Health · CL A | 0.00% | Hold | 11,000 | $13.11 | $144K | — | — |
| ALT - Altimmune | 0.00% | Hold | 27,600 | $5.00 | $138K | — | — |
| EVH - Evolent Health · CL A | 0.00% | Hold | 14,000 | $9.47 | $133K | — | — |
| AM6 - Amicus Therapeutics | 0.00% | Hold | 16,000 | $8.16 | $131K | — | — |
| SNDX - Syndax Pharmaceuticals | 0.00% | Hold | 10,000 | $12.28 | $123K | — | — |
| ARDX - Ardelyx | 0.00% | Hold | 23,000 | $4.91 | $113K | — | — |
| DYN - Dyne Therapeutics | 0.00% | Reduce −95.6% | 10,000 | $10.46 | $105K | −219,121 | −$5M |
| NVAX - Novavax | 0.00% | Hold | 16,000 | $6.41 | $103K | — | — |
| COGT - Cogent Biosciences | 0.00% | Hold | 17,000 | $5.99 | $102K | — | — |
| IOVA - Iovance Biotherapeutics | 0.00% | Hold | 26,000 | $3.33 | $87K | — | — |
| GERN - Geron | 0.00% | Hold | 43,000 | $1.59 | $68K | — | — |
| CCCC - C4 Therapeutics | 0.00% | Hold | 28,000 | $1.60 | $45K | — | — |
| ANNA - Aleanna · CL A | 0.00% | Hold | 78,400 | $0.4465 | $35K | — | — |
| CGC - Canopy Growth | 0.00% | Hold | 30,000 | $0.9100 | $27K | — | — |
| IRWD - Ironwood Pharmaceuticals · CL A | 0.00% | Hold | 13,000 | $1.47 | $19K | — | — |
Showing top 50 of 124 by value
Exits / last held
not current holdings · last reported size, unchanged · gone vs 2024 Q4
| Stock | % of portfolio | Recent activity | Shares | Reported price* | Value | Share change | $ change |
|---|---|---|---|---|---|---|---|
| ABNB - Airbnb · CL A | 1.62% | Exit | 0 | $131.41 | $319M | −2,429,200 | −$319M |
| BMY - Bristol-Myers Squibb | 0.91% | Exit | 0 | $56.56 | $180M | −3,188,000 | −$180M |
| Masimo | 0.33% | Exit | 0 | $165.30 | $66M | −397,000 | −$66M |
| SPY - Spdr S&P 500 ETF Tr | 0.24% | Exit | 0 | $586.09 | $48M | −82,000 | −$48M |
| GDS — | 0.18% | Exit | 0 | $23.76 | $36M | −1,531,133 | −$36M |
| GXO - Gxo Logistics | 0.11% | Exit | 0 | $43.50 | $22M | −513,400 | −$22M |
| Mac Copper | 0.02% | Exit | 0 | $10.62 | $4M | −330,901 | −$4M |
| Elevation Oncology | 0.01% | Exit | 0 | $0.5627 | $2M | −3,527,482 | −$2M |
| HCA - Hca Healthcare | — | Exit | 0 | $300.00 | $300K | −1,000 | −$300K |
| EW - Edwards Lifesciences | — | Exit | 0 | $74.00 | $222K | −3,000 | −$222K |
| Icu Med | — | Exit | 0 | $155.00 | $217K | −1,400 | −$217K |
| ICLR - ICON | — | Exit | 0 | $210.00 | $210K | −1,000 | −$210K |
| Beyond Meat | — | Exit | 0 | $3.74 | $71K | −19,000 | −$71K |
Filings history
20 periods · normalized AUM · open a period for holdings
| Period | Holdings | AUM | QoQ | Form | Filed | Filing ID |
|---|---|---|---|---|---|---|
| 2026 Q2 | 89 | $21.7B | +23.6% | 13F-HR | 8/14/2026 | 000090883426000432 |
| 2026 Q1 | 1 | $1.5B | — | new holds | 8/14/2026 | 000090883426000434 |
| 2026 Q1 | 172 | $17.5B | −17.2% | 13F-HR | 5/15/2026 | 000090883426000240 |
| 2025 Q4 | 1 | $1B | — | new holds | 8/14/2026 | 000090883426000433 |
| 2025 Q4 | 2 | $884M | — | new holds | 5/15/2026 | 000090883426000241 |
| 2025 Q4 | 151 | $21.2B | −13.2% | 13F-HR | 2/17/2026 | 000090883426000087 |
| 2025 Q3 | 144 | $24.4B | — | RESTATEMENT | 2/17/2026 | 000090883426000086 |
| 2025 Q3 | 144 | $24.4B | +5.4% | 13F-HR | 11/14/2025 | 000090883425000353 |
| 2025 Q2 | 1 | $140M | — | new holds | 2/17/2026 | 000090883426000085 |
| 2025 Q2 | 3 | $483M | — | new holds | 11/14/2025 | 000090883425000352 |
| 2025 Q2 | 141 | $23.2B | +29.2% | 13F-HR | 8/14/2025 | 000090883425000248 |
| 2025 Q1 | 1 | $274M | — | new holds | 2/17/2026 | 000090883426000084 |
| 2025 Q1 | 3 | $416M | — | new holds | 11/14/2025 | 000090883425000351 |
| 2025 Q1 | 7 | $2.2B | — | new holds | 8/14/2025 | 000090883425000247 |
| 2025 Q1 | 135 | $17.9B | −9.0% | 13F-HR | 5/15/2025 | 000090883425000177 |
| 2024 Q4 | 1 | $85M | — | new holds | 2/17/2026 | 000090883426000083 |
| 2024 Q4 | 2 | $349M | — | new holds | 11/14/2025 | 000090883425000350 |
| 2024 Q4 | 6 | $2.3B | — | new holds | 8/14/2025 | 000090883425000246 |
| 2024 Q4 | 4 | $333M | — | new holds | 5/15/2025 | 000090883425000180 |
| 2024 Q4 | 138 | $19.7B | −3.5% | 13F-HR | 2/14/2025 | 000090883425000081 |
| 2024 Q3 | 1 | $145M | — | new holds | 11/14/2025 | 000090883425000349 |
| 2024 Q3 | 6 | $1.5B | — | new holds | 8/14/2025 | 000090883425000243 |
| 2024 Q3 | 3 | $216M | — | new holds | 5/15/2025 | 000090883425000179 |
| 2024 Q3 | 2 | $544M | — | new holds | 2/14/2025 | 000090883425000080 |
| 2024 Q3 | 153 | $20.4B | −3.6% | 13F-HR | 11/14/2024 | 000090883424000307 |
| 2024 Q2 | 1 | $120M | — | new holds | 11/14/2025 | 000090883425000348 |
| 2024 Q2 | 5 | $1.2B | — | new holds | 8/14/2025 | 000090883425000245 |
| 2024 Q2 | 1 | $199M | — | new holds | 5/15/2025 | 000090883425000178 |
| 2024 Q2 | 2 | $452M | — | new holds | 2/14/2025 | 000090883425000079 |
| 2024 Q2 | 1 | $149M | — | new holds | 11/14/2024 | 000090883424000324 |
| 2024 Q2 | 157 | $21.2B | −4.2% | 13F-HR | 8/14/2024 | 000090883424000200 |
| 2024 Q1 | 1 | $93M | — | new holds | 11/14/2025 | 000090883425000347 |
| 2024 Q1 | 4 | $1.2B | — | new holds | 8/14/2025 | 000090883425000244 |
| 2024 Q1 | 2 | $159M | — | new holds | 2/14/2025 | 000090883425000078 |
| 2024 Q1 | 1 | $45M | — | new holds | 8/14/2024 | 000090883424000202 |
| 2024 Q1 | 167 | $22.1B | — | RESTATEMENT | 5/24/2024 | 000090883424000159 |
| 2024 Q1 | 167 | $22.1B | +9.8% | 13F-HR | 5/15/2024 | 000090883424000135 |
| 2023 Q4 | 1 | $65M | — | new holds | 11/14/2025 | 000090883425000346 |
| 2023 Q4 | 2 | $548M | — | new holds | 8/14/2025 | 000090883425000250 |
| 2023 Q4 | 5 | $1.1B | — | new holds | 5/15/2024 | 000090883424000141 |
| 2023 Q4 | 150 | $20.1B | +1.0% | 13F-HR | 2/14/2024 | 000090883424000070 |
| 2023 Q3 | 1 | $40M | — | new holds | 11/14/2025 | 000090883425000345 |
| 2023 Q3 | 1 | $40M | — | new holds | 5/15/2024 | 000090883424000138 |
| 2023 Q3 | 2 | $1.4B | — | new holds | 2/14/2024 | 000090883424000077 |
| 2023 Q3 | 1 | $1.9B | — | new holds | 2/12/2024 | 000090883424000049 |
| 2023 Q3 | 159 | $20B | +11.5% | 13F-HR | 11/14/2023 | 000090883423000150 |
| 2023 Q2 | 2 | $669M | — | new holds | 2/14/2024 | 000090883424000076 |
| 2023 Q2 | 5 | $1.4B | — | new holds | 11/14/2023 | 000090883423000157 |
| 2023 Q2 | 1 | $1.2B | — | new holds | 10/26/2023 | 000090883423000134 |
| 2023 Q2 | 165 | $17.9B | +1.3% | 13F-HR | 8/14/2023 | 000090883423000109 |
| 2023 Q1 | 2 | $234M | — | new holds | 2/14/2024 | 000090883424000075 |
| 2023 Q1 | 3 | $389M | — | new holds | 11/14/2023 | 000090883423000156 |
| 2023 Q1 | 1 | $15M | — | new holds | 8/14/2023 | 000090883423000110 |
| 2023 Q1 | 187 | $17.7B | +15.8% | 13F-HR | 5/15/2023 | 000117570723000127 |
| 2022 Q4 | 1 | $171M | — | new holds | 2/14/2024 | 000090883424000074 |
| 2022 Q4 | 3 | $485M | — | new holds | 11/14/2023 | 000090883423000155 |
| 2022 Q4 | 7 | $1B | — | new holds | 5/15/2023 | 000117570723000136 |
| 2022 Q4 | 232 | $15.3B | −9.3% | 13F-HR | 2/14/2023 | 000117570723000051 |
| 2022 Q3 | 1 | $125M | — | new holds | 2/14/2024 | 000090883424000073 |
| 2022 Q3 | 3 | $415M | — | new holds | 11/14/2023 | 000090883423000154 |
| 2022 Q3 | 5 | $411M | — | new holds | 5/15/2023 | 000117570723000135 |
| 2022 Q3 | 4 | $434M | — | new holds | 2/14/2023 | 000090966123000005 |
| 2022 Q3 | 298 | $16.8B | +3.5% | 13F-HR | 11/14/2022 | 000156761922019851 |
| 2022 Q2 | 1 | $115M | — | new holds | 2/14/2024 | 000090883424000081 |
| 2022 Q2 | 3 | $411M | — | new holds | 11/14/2023 | 000090883423000153 |
| 2022 Q2 | 2 | $337M | — | new holds | 5/15/2023 | 000117570723000134 |
| 2022 Q2 | 3 | $136M | — | new holds | 2/14/2023 | 000090966123000003 |
| 2022 Q2 | 9 | $1.2B | — | new holds | 11/14/2022 | 000156761922019862 |
| 2022 Q2 | 297 | $16.3B | −13.7% | 13F-HR | 8/15/2022 | 000156761922015953 |
| 2022 Q1 | 1 | $268M | — | new holds | 11/14/2023 | 000090883423000152 |
| 2022 Q1 | 1 | $314M | — | new holds | 5/15/2023 | 000117570723000133 |
| 2022 Q1 | 1 | $27M | — | new holds | 2/14/2023 | 000090966123000002 |
| 2022 Q1 | 3 | $186M | — | new holds | 11/14/2022 | 000156761922019864 |
| 2022 Q1 | 8 | $1.1B | — | new holds | 8/15/2022 | 000156761922015972 |
| 2022 Q1 | 307 | $18.8B | +0.4% | 13F-HR | 5/16/2022 | 000156761922010736 |
| 2021 Q4 | 1 | $227M | — | new holds | 5/15/2023 | 000117570723000132 |
| 2021 Q4 | 1 | $7M | — | new holds | 11/14/2022 | 000156761922019852 |
| 2021 Q4 | 1 | $115M | — | new holds | 8/15/2022 | 000156761922015968 |
| 2021 Q4 | 2 | $98M | — | new holds | 5/19/2022 | 000156761922011257 |
| 2021 Q4 | 6 | $833M | — | new holds | 5/16/2022 | 000156761922010757 |
| 2021 Q4 | 289 | $18.7B | −5.1% | 13F-HR | 2/14/2022 | 000156761922003965 |
| 2021 Q3 | 1 | $182M | — | new holds | 5/15/2023 | 000117570723000131 |
| 2021 Q3 | 1 | $105M | — | new holds | 8/15/2022 | 000156761922015964 |
| 2021 Q3 | 1 | $57M | — | new holds | 5/19/2022 | 000156761922011256 |
| 2021 Q3 | 3 | $998M | — | new holds | 5/16/2022 | 000156761922010753 |
| 2021 Q3 | 2 | $344M | — | new holds | 2/14/2022 | 000156761922003981 |
| 2021 Q3 | 293 | $19.7B | — | 13F-HR | 11/15/2021 | 000095012321015168 |
About
FARALLON CAPITAL MANAGEMENT, L.L.C.
87 processed 13Fs on this site · 2021 Q3–2026 Q2